ArticleCancer chemotherapy and pharmacology2021

Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women.

Binghe Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.